MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS IN SERUM OF OVARIAN CANCER PATIENTS CORRELATE WITH POOR PROGNOSTIC PARAMETERS IN OVARIAN CANCER

被引：0
|
作者：
Krockenberger, M. [1 ]
Engel, J. [1 ]
Haeusler, S. [1 ]
Wischhusen, J. [1 ]
Heuer, St. [1 ]
Dietl, J. [1 ]
Hoenig, A. [1 ]
机构：
[1] Univ Frauenklin Wurzburg, Wurzburg, Germany
来源：
ANTICANCER RESEARCH | 2011年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1987 / 1988
页数：2
相关论文
共 50 条
  • [1] Macrophage Migration-inhibitory Factor Levels in Serum of Patients with Ovarian Cancer Correlates with Poor Prognosis
    Krockenberger, Mathias
    Kranke, Peter
    Haeusler, Sebastian
    Engel, Joerg Bernhard
    Horn, Evi
    Nuernberger, Katharina
    Wischhusen, Joerg
    Dietl, Johannes
    Hoenig, Arnd
    [J]. ANTICANCER RESEARCH, 2012, 32 (12) : 5233 - 5238
  • [2] Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients
    Tas, Faruk
    Karabulut, Senem
    Serilmez, Murat
    Ciftci, Rumeysa
    Duranyildiz, Derya
    [J]. TUMOR BIOLOGY, 2014, 35 (04) : 3327 - 3331
  • [3] Macrophage migration inhibitory factor expression in ovarian cancer
    Agarwal, Rinki
    Whang, Dong Hee
    Alvero, Ayesha B.
    Visintin, Irene
    Lai, Yinglei
    Segal, Elliot A.
    Schwartz, Peter
    Ward, David
    Rutherford, Thomas
    Mor, Gil
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (04) : 348.e1 - 348.e5
  • [4] Thrombocytosis as a poor prognostic factor in ovarian cancer
    Jorgensen, T.
    Teiblum, S. T.
    Paludan, M.
    Poulsen, L. O.
    Jorgensen, A. Y. S.
    Bruun, K. H.
    Herrstedt, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S718 - S718
  • [5] Serum macrophage migration inhibitory factor concentration as a prostate cancer prognostic marker
    Meyer-Siegler, KL
    Tannenbaum, M
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 287 - 288
  • [6] Serum macrophage migration inhibitory factor is not elevated in patients with prostate cancer
    Michael, A
    Stephan, C
    Schnorr, D
    Loening, SA
    Jung, K
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (02) : 328 - 329
  • [7] PREOPERATIVE THROMBOCYTOSIS IS AN INDEPENDENT POOR PROGNOSTIC FACTOR IN PATIENTS WITH OVARIAN CANCER
    Lee, C.
    Oh, J. S.
    Choi, M. C.
    Park, H.
    Joo, W. D.
    Lee, J. M.
    Lee, J. H.
    Hwang, Y. Y.
    Kim, S. J.
    Ahn, H. J.
    Chong, S. Y.
    Oh, D. Y.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 60 - 60
  • [8] Macrophage migration inhibitory factor levels correlate with an infection in trauma patients
    Cho, Young-Duck
    Choi, Sung-Hyuk
    Kim, Jung-Youn
    Park, Sung-Jun
    Yoon, Young-Hoon
    Cho, Han-Jin
    Yeom, Ji-Won
    [J]. ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2017, 23 (03): : 193 - 198
  • [9] Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder
    Tsukishiro, Sami
    Suzumori, Nobuhiro
    Nishikawa, Hiroshi
    Arakawa, Atsushi
    Suzumori, Kaoru
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 102 (03) : 542 - 545
  • [10] Serum Macrophage Migration-Inhibitory Factor as a Diagnostic and Prognostic Biomarker for Gastric Cancer
    Xia, Harry Hua-Xiang
    Yang, Yi
    Chu, Kent-Man
    Gu, Qing
    Zhang, Yuan-Yuan
    He, Hua
    Wong, Wai Man
    Leung, Suet-Yi
    Yuen, Siu-Tsan
    Yuen, Man-Fung
    Chan, Annie O. O.
    Wong, Benjamin C. Y.
    [J]. CANCER, 2009, 115 (23) : 5441 - 5449
12345